Fairvalue-Calculator Fairvalue-Calculator
EN DE

AcouSort AB (ACOU) Fair Value & Analysis

Healthcare · SE · Market cap 99.0M SEK

Pricekr 4.01
Fair Valuekr 3.47
Upside-13.5%
Quality95/100
Evidence: Low Range kr 2.60 – kr 4.33

Fair value as of: Jun 24, 2026

✦ Find undervalued quality stocks — 34,000+ analysed Find stocks →

Analysis

AcouSort AB (ACOU) currently trades at kr 4.01, while our model-based Fair Value estimate is kr 3.47 — implying the stock looks roughly 13.5% overvalued today. We read business quality at 95/100 (high quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: low).

About the company

AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, a module that enables in-line analysis of blood plasma from whole blood samples; Acoustic Separation Module, a microfluidic solution that provides continuous separation, washing or up-concentration of cells; Acoustic Trapping Module, a microfluidic cell sorters or quality control systems for bioreactors and cell therapy production; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has a collaboration agreement with Moeller Medical to exhibit a prototype system for analyzing separation of cells fr…

Open the full interactive analysis →

Similar stocks

Vertex Pharmaceuticals Incorporated (VRTX34) -88% Regeneron Pharmaceuticals, Inc (REGN) -14% UCB SA (UCB) -27% argenx SE (ARGNF) -57% Samsung Biologics Co (207940) +9% Alnylam Pharmaceuticals, Inc (ALNY) -62%

Frequently asked questions

Is AcouSort AB (ACOU) undervalued?
As of Jun 24, 2026, our model estimates a fair value of kr 3.47 versus a price of kr 4.01 — about −13% (overvalued). Model-based estimate, not financial advice.
What is the fair value of ACOU?
Our 21-model fair value for AcouSort AB is kr 3.47 (as of Jun 24, 2026), built from audited fundamentals. The current price is kr 4.01.
What is the quality score of ACOU?
AcouSort AB has a Quality Score of 95/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.